Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02624375 · ClinicalTrials.gov registry record · Phase 4
Immune Response to Shingles Vaccination
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT02624375 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 10 participants.
The verdict
NCT02624375, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the immune response to varicella zoster virus (VZV).
Interventions
- DRUG Zoster Vaccine Live
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02624375
The ClinicalTrials.gov registry entry for NCT02624375 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zoster Vaccine Live is the first listed.
NCT02624375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02624375 about?
NCT02624375 is a clinical study titled "Immune Response to Shingles Vaccination". The purpose of this study is to learn more about the immune response to varicella zoster virus (VZV).
What is the current status of trial NCT02624375?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2016-02. Estimated completion is 2019-11.
What interventions are being tested in trial NCT02624375?
The interventions under investigation include: Zoster Vaccine Live (DRUG).
Who is sponsoring clinical trial NCT02624375?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.